By: IPP Bureau
Last updated : May 06, 2025 4:29 pm
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025
Onesource Specialty Pharma Limited has reported consolidated financial results for the period ended March 31, 2025.
Onesource Specialty Pharma has posted net profit of Rs. 98.50 crores for the period ended March 31, 2025 as against net loss of Rs. 68.84 crores for the period ended December 31, 2024. The company posted net loss of Rs. 40.17 crores for the period ended March 31, 2024.
Onesource Specialty Pharma has reported total income of Rs. 428.84 crores during the period ended March 31, 2025 as compared to Rs. 399.28 crores during the period ended December 31, 2024. The company reported total income of Rs. 75.77 crores during the period ended March 31, 2024.
For the Financial Year ended March 31, 2025, Onesource Specialty Pharma has reported total income of Rs. 1,462.32 crores during the Financial Year ended March 31, 2025 as compared to Rs. 176.14 crores during the Financial Year ended March 31, 2024.
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025 as against net loss of Rs. 391.16 crores for the Financial Year ended March 31, 2024.
OneSource Specialty Pharma reports consolidated Q4 FY25 PAT at Rs . 98.50 Cr
Onesource Specialty Pharma Limited has reported consolidated financial results for the period ended March 31, 2025.
Onesource Specialty Pharma has posted net profit of Rs. 98.50 crores for the period ended March 31, 2025 as against net loss of Rs. 68.849 crores for the period ended December 31, 2024. The company posted net profit loss of Rs. 40.17 crores for the period ended March 31, 2024.
Onesource Specialty Pharma has reported total income of Rs. 428.84 crores during the period ended March 31, 2025 as compared to Rs. 399.28 crores during the period ended December 31, 2024. The company reported total income of Rs. 75.77 crores during the period ended March 31, 2024.
For the Financial Year ended March 31, 2025, Onesource Specialty Pharma has reported total income of Rs. 1,462.32 crores during the Financial Year ended March 31, 2025 as compared to Rs. 176.14 crores during the Financial Year ended March 31, 2024.
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025 as against net loss of Rs. 391.16 crores for the Financial Year ended March 31, 2024.